[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Heartsciences Inc (HSCS)

Heartsciences Inc (HSCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,338
  • Shares Outstanding, K 3,185
  • Annual Sales, $ 4 K
  • Annual Income, $ -8,770 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 2.03
  • Price/Sales 495.98
  • Price/Cash Flow N/A
  • Price/Book 2.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $-0.68
  • Number of Estimates 1
  • High Estimate $-0.68
  • Low Estimate $-0.68
  • Prior Year $-1.88
  • Growth Rate Est. (year over year) +63.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8900 +7.94%
on 04/14/26
2.3800 -14.11%
on 04/08/26
-0.2600 (-11.30%)
since 04/02/26
3-Month
1.8900 +7.94%
on 04/14/26
3.2500 -37.23%
on 02/10/26
-0.8900 (-30.38%)
since 02/04/26
52-Week
1.8900 +7.94%
on 04/14/26
6.4700 -68.47%
on 07/10/25
-1.5600 (-43.33%)
since 05/02/25

Most Recent Stories

More News
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

Southlake, TX, April 14, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”) a healthcare information technology (“HIT”) company focused...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category

Southlake, TX , March 25, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings

Southlake, TX, March 24, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center

Southlake, TX, Feb. 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.    ( Nasdaq: HSCS; HSCSW ) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals

Southlake, TX, Jan. 29, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device

Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1

Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc.   (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company advancing...

HSCSW : 0.0659 (+2.97%)
HSCS : 2.0400 (+2.51%)
Heart Test Laboratories Announces Successful Regulation A Offering

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Heart Test...

HSCS : 2.0400 (+2.51%)

Business Summary

Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare...

See More

Key Turning Points

3rd Resistance Point 2.2200
2nd Resistance Point 2.1500
1st Resistance Point 2.0900
Last Price 2.0400
1st Support Level 1.9700
2nd Support Level 1.9000
3rd Support Level 1.8400

See More

52-Week High 6.4700
Fibonacci 61.8% 4.7200
Fibonacci 50% 4.1800
Fibonacci 38.2% 3.6400
Last Price 2.0400
52-Week Low 1.8900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.